This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201100029C-2-0-1
Application #
8735032
Study Section
Project Start
2011-09-27
Project End
2015-02-28
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$9,218,951
Indirect Cost
Name
Enanta Pharmaceuticals, Inc.
Department
Type
DUNS #
943565028
City
Watertown
State
MA
Country
United States
Zip Code
02472